SMS Pharmaceuticals Limited
NSE:SMSPHARMA.NS
364.4 (INR) • At close September 16, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SMS Pharmaceuticals Limited |
Symbool | SMSPHARMA.NS |
Munteenheid | INR |
Prijs | 364.4 |
Beurswaarde | 30,847,188,800 |
Dividendpercentage | 0.15% |
52-weken bereik | 111.85 - 391.65 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Ramesh Babu Potluri |
Website | https://www.smspharma.com |
An error occurred while fetching data.
Over SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)